Business · 15/10/2009Updated: 10/17/2026 · 1 min read

FDA Approves New Animal Drug for Use in Animal Feeds, Revises Tylosin Phosphate Limitations

The US Food and Drug Administration (FDA) has amended its regulations to reflect the approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, a division of Eli Lilly & Co., which revises the limitations for liquid Type B medicated cattle feeds containing tylosin phosphate.